Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Evaluation of the lung immune prognostic index for prediction of survival and response in patients treated with atezolizumab for non-small cell lung cancer: pooled analysis of clinical trials.

Sorich MJ, Rowland A, Karapetis CS, Hopkins AM.

J Thorac Oncol. 2019 Apr 15. pii: S1556-0864(19)30285-0. doi: 10.1016/j.jtho.2019.04.006. [Epub ahead of print]

PMID:
30999110
2.

Internet use and preferences among women living with advanced breast cancer.

Kemp E, Koczwara B, Turner J, Girgis A, Schofield P, Hulbert-Williams N, Levesque J, Spence D, Vatandoust S, Kichenadasse G, Roy A, Sukumaran S, Karapetis CS, Richards C, Fitzgerald M, Beatty L.

Breast J. 2019 Mar;25(2):290-295. doi: 10.1111/tbj.13203. Epub 2019 Feb 21.

PMID:
30790383
3.

First-line therapy for metastatic colorectal cancer: Current perspectives and future directions.

Burge M, Price T, Karapetis CS.

Asia Pac J Clin Oncol. 2019 Feb;15 Suppl 1:3-14. doi: 10.1111/ajco.13119. Review.

PMID:
30758881
4.

The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology.

Lwin Z, Broom A, Sibbritt D, Francis K, Karapetis CS, Karikios D, Harrup R.

Semin Oncol. 2018 Oct;45(5-6):284-290. doi: 10.1053/j.seminoncol.2018.06.004. Epub 2018 Oct 24.

5.

Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study.

Shapiro JD, Thavaneswaran S, Underhill CR, Robledo KP, Karapetis CS, Day FL, Nott LM, Jefford M, Chantrill LA, Pavlakis N, Tebbutt NC, Price TJ, Khasraw M, Van Hazel GA, Waring PM, Tejpar S, Simes J, Gebski VJ, Desai J, Segelov E.

Clin Colorectal Cancer. 2018 Dec;17(4):313-319. doi: 10.1016/j.clcc.2018.06.002. Epub 2018 Jun 8.

PMID:
30463680
6.

Author reply.

Karapetis CS; Medical Oncology Group of Australia.

Intern Med J. 2018 Nov;48(11):1415-1416. doi: 10.1111/imj.14095. No abstract available.

PMID:
30387306
7.

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials.

Hopkins AM, Nguyen AM, Karapetis CS, Rowland A, Sorich MJ.

Cancers (Basel). 2018 Oct 15;10(10). pii: E384. doi: 10.3390/cancers10100384.

8.

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators.

N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.

PMID:
30280658
9.

Serum vitamin D decreases during chemotherapy: an Australian prospective cohort study.

Isenring EA, Teleni L, Woodman RJ, Kimlin MG, Walpole E, Karapetis CS, Shawgi S, Kichenadasse G, Marshall S, Koczwara B.

Asia Pac J Clin Nutr. 2018;27(5):962-967. doi: 10.6133/apjcn.042018.01.

10.

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers.

Saluja H, Karapetis CS, Pedersen SK, Young GP, Symonds EL.

Front Oncol. 2018 Jul 24;8:275. doi: 10.3389/fonc.2018.00275. eCollection 2018. Review.

11.

The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern.

Prasanna T, Karapetis CS, Roder D, Tie J, Padbury R, Price T, Wong R, Shapiro J, Nott L, Lee M, Chua YJ, Craft P, Piantadosi C, Sorich M, Gibbs P, Yip D.

Acta Oncol. 2018 Nov;57(11):1438-1444. doi: 10.1080/0284186X.2018.1487581. Epub 2018 Jul 23.

PMID:
30035653
12.

Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival.

Murray DH, Symonds EL, Young GP, Byrne S, Rabbitt P, Roy A, Cornthwaite K, Karapetis CS, Pedersen SK.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1741-1750. doi: 10.1007/s00432-018-2701-x. Epub 2018 Jul 10.

PMID:
29992492
13.

Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing.

Chiam K, Mayne GC, Watson DI, Woodman RJ, Bright TF, Michael MZ, Karapetis CS, Irvine T, Phillips WA, Hummel R, Wang T, Pimlott LK, Marri S, Astill DS, Ruszkiewicz AR, Thompson SK, Hussey DJ.

Ann Surg Oncol. 2018 Sep;25(9):2731-2738. doi: 10.1245/s10434-018-6626-z. Epub 2018 Jul 9.

PMID:
29987600
14.

Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying.

Karapetis CS, Stein B, Koczwara B, Harrup R, Milleshkin L, Parente P, Millward M, Haines I, Blinman P, Olver I.

Intern Med J. 2018 Jul;48(7):774-779. doi: 10.1111/imj.13951.

PMID:
29984513
15.

Online information and support needs of women with advanced breast cancer: a qualitative analysis.

Kemp E, Koczwara B, Butow P, Turner J, Girgis A, Schofield P, Hulbert-Williams N, Levesque J, Spence D, Vatandoust S, Kichenadasse G, Roy A, Sukumaran S, Karapetis CS, Richards C, Fitzgerald M, Beatty L.

Support Care Cancer. 2018 Oct;26(10):3489-3496. doi: 10.1007/s00520-018-4206-1. Epub 2018 Apr 24.

PMID:
29693203
16.

Localised prostate cancer in elderly men aged 80-89 years, findings from a population-based registry.

Vatandoust S, Kichenadasse G, O'Callaghan M, Vincent AD, Kopsaftis T, Walsh S, Borg M, Karapetis CS, Moretti K.

BJU Int. 2018 May;121 Suppl 3:48-54. doi: 10.1111/bju.14228.

17.

Copy number profiles of paired primary and metastatic colorectal cancers.

Kawamata F, Patch AM, Nones K, Bond C, McKeone D, Pearson SA, Homma S, Liu C, Fennell L, Dumenil T, Hartel G, Kobayasi N, Yokoo H, Fukai M, Nishihara H, Kamiyama T, Burge ME, Karapetis CS, Taketomi A, Leggett B, Waddell N, Whitehall V.

Oncotarget. 2017 Dec 15;9(3):3394-3405. doi: 10.18632/oncotarget.23277. eCollection 2018 Jan 9.

18.

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.

Tie J, Cohen JD, Wang Y, Li L, Christie M, Simons K, Elsaleh H, Kosmider S, Wong R, Yip D, Lee M, Tran B, Rangiah D, Burge M, Goldstein D, Singh M, Skinner I, Faragher I, Croxford M, Bampton C, Haydon A, Jones IT, S Karapetis C, Price T, Schaefer MJ, Ptak J, Dobbyn L, Silliman N, Kinde I, Tomasetti C, Papadopoulos N, Kinzler K, Volgestein B, Gibbs P.

Gut. 2019 Apr;68(4):663-671. doi: 10.1136/gutjnl-2017-315852. Epub 2018 Feb 2.

PMID:
29420226
19.

A mixed methods analysis of experiences and expectations among early-career medical oncologists in Australia.

Wong WKT, Kirby E, Broom A, Sibbritt D, Francis K, Karapetis CS, Karikios D, Harrup R, Lwin Z.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e521-e527. doi: 10.1111/ajco.12844. Epub 2018 Jan 26.

PMID:
29377530
20.

Acanthosis Palmaris: A Rare Paraneoplastic Manifestation of Non-Small-Cell Lung Cancer.

Burdett NL, Karapetis CS.

J Oncol Pract. 2018 May;14(5):331-332. doi: 10.1200/JOP.2017.028746. Epub 2018 Jan 22. No abstract available.

PMID:
29356581

Supplemental Content

Loading ...
Support Center